🔗 Permalink

Assignee profile:

Theraclone Sciences, Inc.

City:

Seattle, Washington

Country:

United States

Published Applications:

Last publication date:

2024-10-17

Patent Grants:

Last grant date:

2025-05-27

Top Inventors for applications by Theraclone Sciences, Inc.

These are the the leading inventors for applications assigned to Theraclone Sciences, Inc.:

Ole Olsen 27 Everett, WA United States
Jennifer Mitcham 26 Redmond, WA United States
Matthew Moyle 20 Redmond, WA United States
Po-Ying Chan-Hui 16 Bellevue, WA United States

Steven Frey 15 Redmond, WA United States
Pascal Raymond Georges Poignard 14 San Diego, CA United States
Melissa Danielle De Jean De St. Marcel Simek-Lemos 14 Brooklyn, NY United States
Dennis R. Burton 14 La Jolla, CA United States

Wayne Koff 14 Stony Brook, NY United States
Stephen Kaminsky 13 Bronx, NY United States
SANJAY K. PHOGAT 11 FREDERICK, MD United States
Gordon King 10 Shoreline, WA United States

Laura Marjorie Walker 10 San Diego, CA United States
Andres G. Grandea, III 9 Shoreline, WA United States
Thomas C. Cox 8 Redmond, WA United States
Matthew Moyle 6 Newtown, CT United States

Michael Huber 6 Zurich, Switzerland
Katherine Doores 6 San Diego, CA United States
Phil Hammond 6 Seattle, WA United States
Laura Majorie Walker 5 San Diego, CA United States

Andres Grandea, III 3 Shoreline, WA United States
Sanjay K. Phogat 3 Edison, NJ United States
Thomas Cox 3 Redmond, WA United States
Ole Olsen 2 Everitt, WA United States

Christina L. Boozer 1 Seattle, WA United States
Gordon KING 1 Seattle, WA United States
THERACLONE SCIENCES, INC. 1 Seattle, WA United States
Ole Olesen 1 Everett, WA United States

Thomas Cox 1 Seattle, WA United States
Matthew Moyle 1 Danbury, CT United States
Jennifer Mitchum 1 Redmond, WA United States

Recent patent applications by Theraclone Sciences, Inc.

Theraclone Sciences, Inc. based in Seattle, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-10-17 ✅ Patent 12,312,396 granted on 2025-05-27

US20240343782A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#2 | 2024-04-25 ✅ Patent 12,410,243 granted on 2025-09-09

US20240132578A1

Chemistry; metallurgy

METHODS OF TREATING HIV-1 INFECTION UTILIZING BROADLY NEUTRALIZING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120-SPECIFIC MONOCLONAL ANTIBODIES

#3 | 2023-09-21 ✅ Patent 12,018,067 granted on 2024-06-25

US20230295278A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#4 | 2023-01-26 ✅ Patent 11,845,789 granted on 2023-12-19

US20230027965A1

Chemistry; metallurgy

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

#5 | 2021-02-11 ✅ Patent 11,584,789 granted on 2023-02-21

US20210040186A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#6 | 2020-01-23 ✅ Patent 11,319,362 granted on 2022-05-03

US20200024330A1

Chemistry; metallurgy

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

#7 | 2019-11-07 ✅ Patent 10,865,234 granted on 2020-12-15

US20190338017A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#8 | 2019-06-06 ✅ Patent 10,407,493 granted on 2019-09-10

US20190169273A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#9 | 2019-01-31 ✅ Patent 10,239,934 granted on 2019-03-26

US20190031742A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#10 | 2018-03-01 ✅ Patent 10,836,811 granted on 2020-11-17

US20180057570A1

Chemistry; metallurgy

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

#11 | 2016-09-15 ✅ Patent 10,087,239 granted on 2018-10-02

US20160264649A1

Chemistry; metallurgy

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

#12 | 2015-08-06 ✅ Patent 9,920,111 granted on 2018-03-20

US20150218257A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#13 | 2014-07-24 ✅ Patent 9,464,131 granted on 2016-10-11

US20140205612A1

Chemistry; metallurgy

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

#14 | 2014-05-15

US20140135480A1

Chemistry; metallurgy

Compositions and Methods for the Therapy and Diagnosis of Influenza

#15 | 2013-06-20

US20130158238A1

Chemistry; metallurgy

Compositions and Methods for the Therapy and Diagnosis of Influenza

#16 | 2013-02-28 ✅ Patent 8,822,651 granted on 2014-09-02

US20130052163A1

Chemistry; metallurgy

Human rhinovirus (HRV) antibodies

#17 | 2012-12-13

US20120315277A1

Human necessities

Compositions and Methods for the Therapy and Diagnosis of Influenza

#18 | 2012-10-18 ✅ Patent 8,852,594 granted on 2014-10-07

US20120263734A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of cytomegalovirus infections

#19 | 2012-10-11 ✅ Patent 8,932,597 granted on 2015-01-13

US20120258077A1

Chemistry; metallurgy

Human M2e peptide immunogens

#20 | 2012-08-16 ✅ Patent 8,916,160 granted on 2014-12-23

US20120207760A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of influenza

#21 | 2012-07-05 ✅ Patent 8,460,671 granted on 2013-06-11

US20120171218A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of influenza

#22 | 2012-05-17 ✅ Patent 8,858,948 granted on 2014-10-14

US20120121603A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of influenza

#23 | 2012-02-16 ✅ Patent 8,900,590 granted on 2014-12-02

US20120039899A1

Chemistry; metallurgy

Anti-hemagglutinin antibody compositions and methods of use thereof

#24 | 2011-12-15 ✅ Patent 8,268,309 granted on 2012-09-18

US20110305708A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of cytomegalovirus

#25 | 2011-03-24 ✅ Patent 8,974,788 granted on 2015-03-10

US20110070235A1

Physics

Compositions and methods for the therapy and diagnosis of influenza

#26 | 2011-02-24 ✅ Patent 9,051,362 granted on 2015-06-09

US20110044994A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#27 | 2011-02-10

US20110033476A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA

#28 | 2010-11-18 ✅ Patent 8,609,101 granted on 2013-12-17

US20100291075A1

Chemistry; metallurgy

Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies

#29 | 2010-07-15 ✅ Patent 8,114,402 granted on 2012-02-14

US20100178295A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of influenza

#30 | 2010-06-03 ✅ Patent 8,329,188 granted on 2012-12-11

US20100135955A1

Chemistry; metallurgy

Human M2e peptide immunogens

#31 | 2009-12-31 ✅ Patent 7,982,012 granted on 2011-07-19

US20090324613A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of cytomegalovirus

#32 | 2009-09-10 ✅ Patent 8,057,796 granted on 2011-11-15

US20090226433A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of influenza

Also check out THERACLONE SCIENCES, INC.'s (Seattle, United States) applicant profile with 13 patent applications submitted.

AssigneeID:

11486 ⎘